In this light, densely granulated tumors usually show a better response to SRL treatment compared to the sparsely granulated ones, possibly due to a relatively higher expression of SST2 on tumor cell membrane, as well as a reduced E-cadherin immunoreactivity (54, 55). This evidence concerns the gene CDH1 and neoplasm.